Terms: = Germ cell tumor AND HLA-A, P01892, 3105, ENSG00000206503, P16188, P30447, P13746, P04439 AND Prognosis
20 results:
1. The fatty acid-related gene signature stratifies poor prognosis patients and characterizes TIME in cutaneous melanoma.
Hua S; Wang W; Yao Z; Gu J; Zhang H; Zhu J; Xie Z; Jiang H
J Cancer Res Clin Oncol; 2024 Jan; 150(2):40. PubMed ID: 38279987
[TBL] [Abstract] [Full Text] [Related]
2. Tryptophanyl-Transfer RNA Synthetase Is Involved in a Negative Feedback Loop Mitigating Interferon-γ-Induced Gene Expression.
Lazar I; Livneh I; Ciechanover A; Fabre B
Cells; 2024 Jan; 13(2):. PubMed ID: 38247871
[TBL] [Abstract] [Full Text] [Related]
3. Uveal melanoma: In the era of new treatments.
Wespiser M; Neidhardt E; Negrier S
Cancer Treat Rev; 2023 Sep; 119():102599. PubMed ID: 37473516
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic survival biomarkers of tumor-fused dendritic cell vaccine therapy in patients with newly diagnosed glioblastoma.
Takei J; Kamata Y; Tanaka T; Fukasawa N; Gomisawa K; Satake M; Mori R; Yamamoto Y; Suzuki T; Oda A; Murahashi M; Fukuda T; Shimoda M; Murayama Y; Akasaki Y
Cancer Immunol Immunother; 2023 Oct; 72(10):3175-3189. PubMed ID: 37382632
[TBL] [Abstract] [Full Text] [Related]
5. Evolving Management of Stage IV Melanoma.
Switzer B; Piperno-Neumann S; Lyon J; Buchbinder E; Puzanov I
Am Soc Clin Oncol Educ Book; 2023 Jan; 43():e397478. PubMed ID: 37141553
[TBL] [Abstract] [Full Text] [Related]
6. Tebentafusp: a novel drug for the treatment of metastatic uveal melanoma.
Wang Z; Xie Y; Wang JQ; Cheng Y; Fleishman J; Chen ZS; Chen Y
Drugs Today (Barc); 2023 Mar; 59(3):179-193. PubMed ID: 36847626
[TBL] [Abstract] [Full Text] [Related]
7. Definition and Characterization of SOX11-Derived T cell Epitopes towards Immunotherapy of Glioma.
Liu Y; Keib A; Neuber B; Wang L; Riemer AB; Bonsack M; Hückelhoven-Krauss A; Schmitt A; Müller-Tidow C; Schmitt M
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768267
[TBL] [Abstract] [Full Text] [Related]
8. Tebentafusp for the treatment of hla-a*02:01-positive adult patients with unresectable or metastatic uveal melanoma.
Chen LN; Carvajal RD
Expert Rev Anticancer Ther; 2022 Oct; 22(10):1017-1027. PubMed ID: 36102132
[TBL] [Abstract] [Full Text] [Related]
9. Role of tumor-Associated Macrophages in the Clinical Course of Pancreatic Neuroendocrine tumors (PanNETs).
Cai L; Michelakos T; Deshpande V; Arora KS; Yamada T; Ting DT; Taylor MS; Castillo CF; Warshaw AL; Lillemoe KD; Ferrone S; Ferrone CR
Clin Cancer Res; 2019 Apr; 25(8):2644-2655. PubMed ID: 30670493
[TBL] [Abstract] [Full Text] [Related]
10. Human lung cancer-derived immunosuppressive plasmacytoid dendritic cells release IL-1α in an AIM2 inflammasome-dependent manner.
Sorrentino R; Terlizzi M; Di Crescenzo VG; Popolo A; Pecoraro M; Perillo G; Galderisi A; Pinto A
Am J Pathol; 2015 Nov; 185(11):3115-24. PubMed ID: 26506473
[TBL] [Abstract] [Full Text] [Related]
11. α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial.
Akiyama Y; Oshita C; Kume A; Iizuka A; Miyata H; Komiyama M; Ashizawa T; Yagoto M; Abe Y; Mitsuya K; Watanabe R; Sugino T; Yamaguchi K; Nakasu Y
BMC Cancer; 2012 Dec; 12():623. PubMed ID: 23270484
[TBL] [Abstract] [Full Text] [Related]
12. Natural HLA class I ligands from glioblastoma: extending the options for immunotherapy.
Neidert MC; Schoor O; Trautwein C; Trautwein N; Christ L; Melms A; Honegger J; Rammensee HG; Herold-Mende C; Dietrich PY; Stevanović S
J Neurooncol; 2013 Feb; 111(3):285-94. PubMed ID: 23263746
[TBL] [Abstract] [Full Text] [Related]
13. Genetic epidemiology of glioblastoma multiforme: confirmatory and new findings from analyses of human leukocyte antigen alleles and motifs.
Song W; Ruder AM; Hu L; Li Y; Ni R; Shao W; Kaslow RA; Butler M; Tang J
PLoS One; 2009 Sep; 4(9):e7157. PubMed ID: 19774073
[TBL] [Abstract] [Full Text] [Related]
14. The common Scandinavian human leucocyte antigen ancestral haplotype 62.1 as prognostic factor in patients with advanced malignant melanoma.
Helgadottir H; Andersson E; Villabona L; Kanter L; van der Zanden H; Haasnoot GW; Seliger B; Bergfeldt K; Hansson J; Ragnarsson-Olding B; Kiessling R; Masucci GV
Cancer Immunol Immunother; 2009 Oct; 58(10):1599-608. PubMed ID: 19214504
[TBL] [Abstract] [Full Text] [Related]
15. A phase I clinical study of vaccination of melanoma patients with dendritic cells loaded with allogeneic apoptotic/necrotic melanoma cells. Analysis of toxicity and immune response to the vaccine and of IL-10 -1082 promoter genotype as predictor of disease progression.
von Euw EM; Barrio MM; Furman D; Levy EM; Bianchini M; Peguillet I; Lantz O; Vellice A; Kohan A; Chacón M; Yee C; Wainstok R; Mordoh J
J Transl Med; 2008 Jan; 6():6. PubMed ID: 18221542
[TBL] [Abstract] [Full Text] [Related]
16. HLA class I and class II frequencies in patients with cutaneous malignant melanoma from southeastern Spain: the role of HLA-C in disease prognosis.
Campillo JA; Martínez-Escribano JA; Muro M; Moya-Quiles R; Marín LA; Montes-Ares O; Guerra N; Sánchez-Pedreño P; Frías JF; Lozano JA; García-Alonso AM; Alvarez-López MR
Immunogenetics; 2006 Jan; 57(12):926-33. PubMed ID: 16365741
[TBL] [Abstract] [Full Text] [Related]
17. Positive and negative associations of human leukocyte antigen variants with the onset and prognosis of adult glioblastoma multiforme.
Tang J; Shao W; Dorak MT; Li Y; Miike R; Lobashevsky E; Wiencke JK; Wrensch M; Kaslow RA; Cobbs CS
Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):2040-4. PubMed ID: 16103458
[TBL] [Abstract] [Full Text] [Related]
18. Human leukocyte antigen class I expression. Marker of poor prognosis in uveal melanoma.
Blom DJ; Luyten GP; Mooy C; Kerkvliet S; Zwinderman AH; Jager MJ
Invest Ophthalmol Vis Sci; 1997 Aug; 38(9):1865-72. PubMed ID: 9286277
[TBL] [Abstract] [Full Text] [Related]
19. MHC antigens in human melanomas.
Ruiter DJ; Mattijssen V; Broecker EB; Ferrone S
Semin Cancer Biol; 1991 Feb; 2(1):35-45. PubMed ID: 1912517
[TBL] [Abstract] [Full Text] [Related]
20. Prolonged N-myc protein half-life in a neuroblastoma cell line lacking N-myc amplification.
Cohn SL; Salwen H; Quasney MW; Ikegaki N; Cowan JM; Herst CV; Kennett RH; Rosen ST; DiGiuseppe JA; Brodeur GM
Oncogene; 1990 Dec; 5(12):1821-7. PubMed ID: 2284101
[TBL] [Abstract] [Full Text] [Related]
